HOME
Hepatitis B
Hepatitis C
HIV and AIDS
HIV-HCV Coinfection
HIV-HBV Coinfection
Hepatitis B Main Section
FDA-approved Treatments
 Experimental Treatments
 HBV Articles by Topic

PEG-Intron - Monotherapy

Pegylated Interferon plus Ribavirin Is Effective for Patients with HCV-HBV Coinfection - 5/09/08

Pegylated Interferon plus Ribavirin in Patients with HBV-HCV Dual Infection  - 4/27/07

Superior Results Using Antiviral Agents Before Pegylated Interferon to Treat Hepatitis B 1/26/07

PegIntron for Treatment of Hepatitis B Patients Who Did Not Respond to Prior Therapy 1/09/07

Treatment with PegInterferon Alfa-2b: HBsAg Loss Is Associated with HBV Genotype - 2/24/06

Predictive Factors for Dose Reduction and Treatment Discontinuation of Peginterferon Alfa-2b in the Treatment of Chronic Hepatitis B - 5/13/05

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


HBV Articles on
FDA-approved Therapies
for Chronic HBV Infection

Baraclude  (entecavir)
 Epivir-HBV  (lamivudine; 3TC)
 Hepsera   (adefovir dipivoxil)
Intron A  (interferon alfa-2b)
Pegasys  (peginterferon alfa-2a)
 Tyzeka   (telbivudine)